Alinity m HCV Assay

alinitym_hcv_assay.png


Accurate quantitation is critical to guide diagnosis to cure Hepatitis C. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma.

  • Dual probe assay within a highly conserved target region of the virus.
  • Accurate quantitation across all genotypes provide confidence in tests results.
  • Streamlined and concurrent HCV confirmation and viral load result from one sample (plasma or serum) provide laboratories and physicians with a solution from Diagnosis to Cure.
INTENDED USe
 

The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for use with the automated Alinity m System to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma. The Alinity m HCV assay is intended for use in the clinical management of HCV-infected patients undergoing antiviral therapy in conjunction with clinical presentation and other laboratory markers. The Alinity m HCV assay may also be used as a diagnostic test to confirm active HCV infection. The results from the Alinity m HCV assay must be interpreted within the context of all relevant clinical and laboratory findings. This assay is not intended to be used in screening blood, blood products, tissue, or organ donors for HCV.

specifications
 

 

ALINITY m HCV ASSAY PERFORMANCE
Limit of Detection (LoD)

 

Plasma: Probit analysis determined that the concentration of HCV RNA in plasma detected with 95% probability was 5.11 IU/mL (95% CI 3.92 to 8.46 IU/mL). ermentum pharetra quam.

Serum: Probit analysis determined that the concentration of HCV RNA in serum detected with 95% probability was 5.11 IU/mL (95% CI 4.16 to 7.47 IU/mL).  

Linear Range 12 IU/mL to 200,000,000 IU/mL 
Target Region Dual Target targeting 5’UTR  
Genotype Detection 1, 2, 3, 4, 5, 6  
Confirmatory Yes
Internal Control Yes 
Specimen Type

 

Plasma: Acid Citrate Dextrose (ACD); K2EDTA; K3EDTA, Plasma Preperation Tubes (PPT)*

Serum: Serum; Serum Separator Tubes (SST)*

*Gel tubes  

Input Volume 600 µL 
Precision Precision < 0.18 Total SD   
Standardization 4th World Health Organization (WHO) [NIBSC code: 06/102; genotype 1]   
Specificity Overall: 100.0% [95% CI: 99.2 to 100.0] 

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No